The government on Monday placed firm orders in advanced commitments for over 6 crore doses of <keyword id="8764262" type="COMPANY" weightage="20" keywordseo="covid">COVID</keyword> vaccine from SII and <keyword id="149108" type="PERSON" weightage="20" keywordseo="Bharat-Biotech">Bharat Biotech</keyword> for inoculating 3 crore healthcare and frontline workers in the first phase of the vaccination drive scheduled to start from January 16, together which will cost Rs 1,300 crore. Sources said the government has placed an order to Bharat Biotech for 55 lakh doses costing Rs 162 crore. The government placed a purchase order with <keyword id="95879" type="COMPANY" weightage="20" keywordseo="Serum-Institute-of-India">Serum Institute of India</keyword> (SII) for 1.1 crore doses of Oxford COVID-19 vaccine, Covishield, each costing Rs 210, including the GST, and committed to buy 4.5 crore more by April, together amounting to over Rs 1,100 crore, sources said. Dispatch of the vaccine is likely to start by early Tuesday morning, they said. According to the order placed, each dose of Covishield has been priced at Rs 200 and with GST of Rs 10, it would cost Rs 210. The HLL Lifecare Limited, a public sector undertaking, issued the supply order on behalf of the <keyword id="83655" type="COMPANY" weightage="20" keywordseo="Union-health-ministry">Union Health Ministry</keyword>. The first order of 1.1 crore doses will be worth Rs 231 crore, while the total amount, including the commitment for 4.5 crore doses, with the total estimated to reach Rs 1,176 crore at current rates, they said. Meanwhile, Prime Minister Narendra Modi announced that the central government will bear the expenses of vaccinating nearly three crore healthcare and frontline workers in the first round and suggested that public representatives, a reference to politicians, should not be part of this initial exercise. Interacting with state chief ministers, Modi underscored the enormity of what he described as the world's biggest vaccination exercise, which begins from January 16, saying over 30 crore citizens will get the jabs in the next few months in India against only 2.5 crore people vaccinated so far in over 50 countries in around a month. The two already approved made-in-India COVID-19 vaccines are more cost-effective than any other in the world and have been developed as per the country's needs, he said at the meeting held over video conference to discuss the COVID-19 situation and the vaccination roll-out. Besides the two vaccines -- Covishield developed by Oxford and British-Swedish company <keyword id="6409874" type="DOMAIN" weightage="20" keywordseo="astrazeneca">AstraZeneca</keyword> and manufactured by Serum Institute of India, and Bharat Biotech's <keyword id="9485939" type="PERSON" weightage="20" keywordseo="covaxin">Covaxin</keyword>, four others are in the pipeline, Modi said, asserting that India's fight against the pandemic will enter a decisive stage with the vaccination roll-out. More vaccines may be available when the exercise moves into the second round, he added. The prime minister also sought to dispel concerns expressed by some opposition leaders and experts over the approval given to Covaxin without the availability of efficacy data, asserting that scientists have taken all precautions to provide citizens with effective vaccines. The prime minister said he has been maintaining from the beginning that the scientific community will have the final word on the issue. India's drug regulator has given nod to Covishield and Covaxin for the emergency use authorisation. PLB KR/ASK BJ AAR AAR

COVID-19 vaccine: India places orders for over 60 million doses from Serum, Bharat Biotech for ₹1,300 crore

New Delhi, Apr 5 () Two samples of Personal Protective Equipment (PPE) made at a Northern Railways workshop have been cleared by the DRDO for their ability to block blood or body fluid, paving the way for its production at railway units.The Northern Railways said on Sunday the test at the Defence Research and Development Organisation's Gwalior lab was conducted to check the resistance of the bio-protective covering material (fabric/garment) to penetration of blood or body fluid. "Now these coveralls will be manufactured by Indian Railways and will be worn by doctors in railway hospitals while treating COVID-19 patients," the Northern Railways said.Its General Manager Rajiv Chaudhary said, "This is a huge achievement for Northern Railways as well as for the Indian Railways. We will continue to supplement the efforts of the government in the fight against coronavirus." There is an acute shortage of PPEs for medical professionals in the country who are treating coronavirus patients.Technical specifications of these PPEs are now ready, and material suppliers are in place, the Northern Railways said.¨We are now making 20 per day, but in a week's time we will be able to make 100 per day," a Northern Railways spokesperson said. The Railway Board has issued necessary instructions to Zonal Railways for production of the PPEs.The Northern Railways' Jagadhari Workshop which developed these sample will share the technical details including specifications of the approved samples and quantities of materials required with other zonal workshops and production units of the Railways, it said.The Indian Railway Stores Department has been designated to procure the material for the production of the PPEs. This internal effort of the Railways is over and above a centralised request projected to the government and also indicated to HLL through Indent, the railways said.According to the Health Ministry, the number of confirmed novel coronavirus cases in the country climbed to 3,374 on Sunday while the death toll rose to 77. Of them, the number of active COVID-19 cases stood at 3,030 and as many as 266 people have been either cured of the disease and discharged, and one had migrated, it said. ASG TIRTIR

Northern Railways' PPE samples clear DRDO test; 100 units a day to be produced soon

New Delhi, May 13 () The ICMR on Wednesday issued guidance on rapid antibody test kits for COVID-19 and listed their manufacturers, which include two Chinese firms whose importer licenses were cancelled by the CDSCO after kits supplied by them showed wide-variation under field conditions. The apex health research body, however, in its guidance clearly stated that these rapid antibody tests are not recommended for diagnosis of COVID-19 infection. The licences of Chinese companies Guangzhou Wondfo Biotech and Zhuhai Livzon Diagnostics were cancelled by the Central Drugs Standard Control Organisation (CDSCO) last month. The names of the two companies find a mention among the firms whose test kits have been validated at NIV Pune till now. The ICMR earlier had said that such test kits are to be used only for surveillance purpose. According to the guidance issued on Wednesday, the ICMR stated these tests can be done on blood/serum/plasma samples, the results of which are available within 30 minutes and the test comes positive after 7-10 days of infection. "The test remains positive for several weeks after infection. Positive test indicates exposure to SARS-CoV-2 while negative test does not rule out COVID-19 infection," it said. "These tests are not recommended for diagnosis of COVID-19 infection," the ICMR stressed. The health research body stated that till date, 42 antibody based rapid tests have been validated at National Institute of Virology, Pune, and the following (list put out in the document) were found to be satisfactory, 10 of which are manufactured in India. "These rapid antibody test kits have been validated in the laboratory. However, the performance of the kits may be subject to variation under field conditions," the ICMR underlined. The list of firms includes Abbott Laboratories Zydus Cadilla, HLL Lifecare Limited, India and SIDAK Life Care Pvt. Ltd among others besides Guangzhou Wondfo Biotech and Zhuhai Livzon Diagnostics. The ICMR listed kits which were validated along with the batch number. Responsibility for batch to batch consistency lies with the manufacturer, it said. The Centre on April 27 had said it has "not lost a single rupee" with respect to the supplies of the COVID-19 rapid antibody test kits while cancelling the shipment of the equipment from two Chinese companies after those were found to be "under performing". In an advisory sent to chief secretaries of all states and UTs, the ICMR had said it "evaluated the kits of Guangzhou Wondfo Biotech and Zhuhai Livzon Diagnostics in field conditions. The results have shown wide variation in their sensitivity, despite early promise of good performance for surveillance purpose". The testing technique is used to detect antibodies in the blood of people who may have had coronavirus infection. PLB ASK AQSAQS

ICMR issues guidance on rapid antibody test kits for COVID-19, lists manufacturers

New Delhi, May 13 () The ICMR on Thursday issued revised guidance document on rapid antibody test kits for COVID-19 and listed the firms whose kits have been validated and found satisfactory.The apex health research body had issued on Wednesday night a guidance document in which two Chinese firms -- Guangzhou Wondfo Biotech and Zhuhai Livzon Diagnostics -- whose importer's licenses were cancelled by the Central Drugs Standard Control Organisation last month, found a mention among the list of companies, test kits of whose, have been validated at the National Institute of Virology (NIV), Pune so far.The document, however, was taken down from the website in the morning and a revised one was uploaded later.The revised document also mentions the two Chinese firms, but states that "the marketing licenses to the distributors of these two companies have been cancelled by the Central Drugs Standard Control Organization (CDSCO)."The health research body, however, underlined that such rapid antibody test are not recommended for diagnosis of coronavirus infection. It had earlier said that such test kits are to be used only for surveillance purpose."Till date, 42 antibody-based rapid tests have been validated, and the following were found to be satisfactory. Ten of these kits are manufactured in India," the ICMR said in the revised guidance document."These rapid antibody test kits have been validated in the laboratory. However, the performance of the kits may be subject to variation under field conditions," the ICMR underlined. According to the guidance document, the rapid tests can be done on blood/serum/plasma samples and the result is available within 30 minutes."The test may remain positive for several weeks after infection. A positive test indicates exposure to SARS-CoV-2 while a negative test does not rule out COVID-19 infection," the ICMR said.The list of kits includes COVID-19 IgM IgG Rapid Test: BioMedomics (CE-IVD); New Coronavirus (COVID-19) IgG/IgM Rapid Test: Voxtur Bio Ltd, India; Makesure COVID-19 Rapid test: HLL Lifecare Limited, Indi; Abchek COVID-19 IgM/IgG Antibody Rapid Test: NuLifecare and; One Step COVID-19 IgM/IgG Antibody: SIDAK Life Care Pvt. Ltd. The list also mentions the batch numbers of the kits.The Centre on April 27 had said that it has "not lost a single rupee" with respect to the supplies of the COVID-19 rapid antibody test kits while cancelling the shipment of the equipment from two Chinese companies after those were found to be "under-performing". In an advisory sent to chief secretaries of all states and Union Territories, the ICMR had said that it "evaluated the kits of Guangzhou Wondfo Biotech and Zhuhai Livson Diagnostics in field conditions. The results have shown wide variation in their sensitivity, despite an early promise of good performance for surveillance purpose".The testing technique is used to detect antibodies in the blood of people who may have had novel coronavirus infection. PLB ASK NSDNSD

ICMR issues revised guidance document on rapid antibody test kits for COVID-19

<ul class="summary-list"><li>Today's budget printers don't skimp on features or print quality and come loaded with additional functions like copy, scan, and even fax.</li><li>For our guide to the best budget printers, we focused on models priced under a hundred dollars.</li><li>With its plentiful features, great print quality, and very low price, our pick for the best cheap printer is the <a href="https://amzn.to/2P95MjN" target="_blank" rel="nofollow noopener">Canon Pixma TR4520</a>. Following close behind is our second favorite, the <a href="https://amzn.to/2Eg1i4J" target="_blank" rel="nofollow noopener">Epson Expression Premium XP-7100</a>.</li></ul>Whether you need to churn out pages upon pages of a college class essay, scan receipts, create graphics for a scrapbook, or make copies of a business contract, a modern printer is a handy computing peripheral to have around. Even if your printing needs are limited, many printers today can do more than just print, and they are relatively compact and operate wirelessly, so they can be tucked away in a closet or cabinet.And don't let a small budget hold you back: For a low price, you can get a high-quality printer that produces crisp text and colorful photos. You'll also find that many affordable printers are multifunction units that can scan, copy, and even fax, and include useful features like an automatic document feeder, auto-duplexing (two-sided), and wireless connectivity. With these extras, a printer is a great tool for digitizing hard-copy documents, even if you never print a single page.Budget models tend to use inkjet technology, but there are also good laser options. Affordable laser printers are generally barebones and print in only black and white, but our recommendation is fast and reliable, and makes great-quality prints. Do keep in mind that while these printers aren't expensive to buy, they can be expensive to maintain, particularly inkjet models. This is the case if you print often, or you make a lot of high-quality color prints like photos or scrapbook printables. Heavy-duty users should look at the cost of ink replacement and the page yields before investing in a unit. Also, while we tried to pick products from reliable brands, printers are mechanical - with many moving parts, they can fail.As a tech journalist who has covered printers for nearly 15 years, I have tested a variety of models, from single-function inkjet devices to wide-format photo printers and high-end, multifunction laser units. Considering pricing, features, ease of use, and reliability, these are the best budget printers.<h2>Here are the best budget printers you can buy:</h2><ul class="summary-list"><li>Best budget printer overall: <a href="https://www.amazon.com/gp/product/B07G5XZVLG/ref=as_li_tl?ie=UTF8&amp;tag=biipg_120919_best-printers-under-100-20&amp;camp=1789&amp;creative=9325&amp;linkCode=as2&amp;creativeASIN=B07G5XZVLG&amp;linkId=8d1bcada8e01105c0de9a8510267bf88" target="_blank" rel="noopener noreferrer nofollow nofollow nofollow">Canon Pixma TR4520</a> </li><li>Best budget photo printer: <a href="https://www.amazon.com/gp/product/B07FN93WW7/ref=as_li_tl?ie=UTF8&amp;tag=biipg_120919_best-printers-under-100-20&amp;camp=1789&amp;creative=9325&amp;linkCode=as2&amp;creativeASIN=B07FN93WW7&amp;linkId=6eddd1bd9cc9d92fd47c061df8c17d80" target="_blank" rel="noopener nofollow">Epson Expression Premium XP-7100</a></li><li>Best budget compact printer: <a href="https://www.amazon.com/gp/product/B01GAIU7HG/ref=as_li_tl?ie=UTF8&amp;tag=biipg_120919_best-printers-under-100-20&amp;camp=1789&amp;creative=9325&amp;linkCode=as2&amp;creativeASIN=B01GAIU7HG&amp;linkId=0ff299a7b62b7794c06ab5376f171646" target="_blank" rel="noopener noreferrer nofollow">HP DeskJet 3755</a></li><li>Best budget laser printer: <a href="https://www.amazon.com/gp/product/B07FN93WW7/ref=as_li_tl?ie=UTF8&amp;tag=biipg_120919_best-printers-under-100-20&amp;camp=1789&amp;creative=9325&amp;linkCode=as2&amp;creativeASIN=B07FN93WW7&amp;linkId=6eddd1bd9cc9d92fd47c061df8c17d80" target="_blank" rel="noopener nofollow"></a><a href="https://www.amazon.com/gp/product/B00LEA5EHO/ref=as_li_tl?ie=UTF8&amp;tag=biipg_120919_best-printers-under-100-20&amp;camp=1789&amp;creative=9325&amp;linkCode=as2&amp;creativeASIN=B00LEA5EHO&amp;linkId=65ce7e37608bbe8b73c9809ddcb9058c" target="_blank" rel="noopener noreferrer nofollow">Brother HLL2320D</a></li><li>Best budget color laser alternative: <a href="https://www.amazon.com/gp/product/B07JMF95S9/ref=as_li_tl?ie=UTF8&amp;tag=biipg_120919_best-printers-under-100-20&amp;camp=1789&amp;creative=9325&amp;linkCode=as2&amp;creativeASIN=B07JMF95S9&amp;linkId=a96af38ed3e7d69b0486c6c8a28479e1" target="_blank" rel="noopener noreferrer nofollow nofollow nofollow">Epson WorkForce Pro WF-3730</a></li></ul>Updated on 12/10/2019 by Les Shu: Replaced all recommendations with newer options. Updated copy and formatting.<a href="http://e.businessinsider.com/join/ci/insider-picks">Subscribe to our newsletter.</a> Find all the best offers at our <a href="https://coupons.businessinsider.com/">Coupons page</a>. Disclosure: This post is brought to you by the <a href="http://www.businessinsider.com/insiderpicks">Insider Picks</a> team. We highlight products and services you might find interesting. If you buy them, we get a small share of the revenue from the sale from our commerce partners. We frequently receive products free of charge from manufacturers to test. This does not drive our decision as to whether or not a product is featured or recommended. We operate independently from our advertising sales team. We welcome your feedback. Email us at insiderpicks@businessinsider.com.

The best budget printers

<div class="KonaFilter image-container display-table"><div><div class="image on-image">Alex Goodlett/AP</div></div></div><ul><li>The Indiana Pacers have pushed the Cleveland Cavaliers to a decisive Game 7.</li><li>LeBron James' teams have never struggled so mightily in the first round of the playoffs, and it's sign that James doesn't have the help he needs on the team.</li><li>If the Cavs get eliminated, it will immediately raise questions about James' future as he enters free agency with the chance to join another team.</li></ul> Going into these <a href="http://www.businessinsider.com/category/nba-playoffs-2018">NBA playoffs</a>, LeBron James hadn't lost a first-round game since 2012.Now, on Sunday, there is a possibility James could exit the playoffs without winning a single series.The Cleveland Cavaliers have been given all they can handle against the Indiana Pacers, a feisty underdog that has arguably outplayed the Cavs in the series. They've pushed the Cavs to a decisive Game 7 on Sunday with the chance to knock out the team everyone thought would walk to the NBA Finals for a fourth year in a row.The Pacers won Game 1 in Cleveland. They were a missed, wide-open, game-tying three-pointer from Victor Oladipo in Game 2 from going up 2-0.In Game 5 in Cleveland, <a href="http://www.businessinsider.com/lebron-james-game-winner-vs-pacers-saves-cavs-2018-4">James saved the Cavs</a> from blowing a lead with a game-saving block and game-winning three-pointer to put them up 3-2 in the series. Indiana responded by blowing out the Cavs in Game 6 to even the series and force a Game 7.Since returning to the Cavs, James hasn't faced an Eastern Conference playoff foe that has truly given him trouble. The Chicago Bulls came the closest in 2014-15, but the Cavs still won that series in six games. Last year, the Cavs swept through the East to make the Finals.<h2>LeBron's free agency looms large.</h2>Contending teams have been pushed in first-round series before, but few have ever had the stakes of this Cavs team, and it's all because of James.James' free agency looms large over the league. It once seemed impossible that James would test the free agency waters again (though he's opted out each summer since returning to Cleveland, it was always just to re-up his contract and keep the pressure on the Cavs) but last summer, <a href="http://www.businessinsider.com/lebron-james-lakers-rumors-growing-2017-6">whispers began that James could leave the Cavs</a> in the summer of 2018. It's difficult to pinpoint what team James could or would join. Would he really join a Western Conference team where he'd only have to face the Golden State Warriors earlier in the postseason? As <a href="http://www.espn.com/espnradio/play?id=23297280">ESPN's Brian Windhorst noted on "The Lowe Post" podcast</a>, James has such power in the league that he can pick whichever team he wants and make it happen.While leaving Cleveland for a second time would be a gut-punch to the city and organization, it's hard to see what would keep him there. There's little help on the horizon, other than the <a href="http://www.businessinsider.com/cavs-trade-rumors-pressure-nets-pick-2018-1">Brooklyn Nets' lottery pick</a> the Cavs own this June. Even still, James hasn't been one to rely on rookies for help, instead favoring the experience that veteran players begin. He essentially ordered the trade in 2014 that sent No. 1 pick Andrew Wiggins to the Minnesota Timberwolves for Kevin Love.James has shouldered an almost impossible load just to keep the Cavs afloat against the Pacers. The <a href="http://www.businessinsider.com/cavs-explained-dwyane-wade-trade-lebron-james-2018-2">pieces acquired at the Cavs' hectic trade deadline</a> haven't helped at all. George Hill has missed three games with back spasms. Love is playing through a thumb injury that many suspect is throwing him off more than he's revealed. Cavs veterans like J.R. Smith and Tristan Thompson are no longer the role players James could rely on. Thompson is struggling to even crack the rotation.That combination of players above - Love, Hll, Smith, Thompson, Larry Nance Jr., and Jordan Clarkson (the latter two acquired at the deadline) are owed almost $90 million next year. The Cavs don't have the financial ability to improve this team. Barring some major trade - and the Cavs have few attractive assets to lure another star - this is their roster.The Cavs desperately miss the <a href="http://www.businessinsider.com/kyrie-irving-trades-cavs-problem-warriors-2017-7">one-on-one scoring ability of Kyrie Irving</a>, who bailed out Cavs possessions in the playoffs perhaps even more than people even realized. James is the Cavs' go-to scorer and facilitator and has struggled to go full-tilt because of the heavy minutes he's played. He's played 245 minutes of a possible 288 so far this postseason - or an average of seven minutes of rest per game.One league source familiar with the Cavs noted that perhaps the only player on the Cavs James trusts right now is Kyle Korver. The same source said James looks frustrated and teetering on giving up - something apparent every time James doesn't sprint back on defense after a turnover or sulks after the Cavs' leaky defense cedes an open basket to the Pacers.<div class="KonaFilter image-container display-table"><div><div class="image on-image">Christian Petersen/Getty</div></div></div>It's possible that Sunday is James' final game with the Cavs. Of course, no one in the NBA boasts James' resume in Game 7s, and the Cavs will be favorites for simply having James on their side on their home court.But it stands to reason that if the Cavs' first-round opponent has given them this much trouble, the rest of the journey won't be any easier.The entire league will be watching closely on Sunday. If James and the Cavs fall short, the biggest story in the NBA will begin right away - what will James do next? <div class="margin-top"> <h3>NOW WATCH: <a href="http://www.businessinsider.com/nba-referee-zach-zarba-basketball-official-job-athlete-2018-4">What it takes to be an NBA referee</a></h3> <div> </div> </div>

LeBron James is being tested like never before in the playoffs, and the biggest question in the NBA hangs over it

<div class="image-container display-table float_right"><div><div class="image"><a href="http://www.youtube.com/watch?v=YqCY9cYfJ7A">GatesFoundation/YouTube</a></div></div></div>Out of 812 submissions to a <keyword id="6360717" type="PERSON" weightage="60" keywordseo="contest">contest</keyword> intended to <a href="http://www.gatesfoundation.org/Media-Center/Press-Releases/2013/11/Gates-Foundation-Awards-Grants-to-Test-Ideas-2">create the condom of the future</a>, the <a href="http://www.gatesfoundation.org/">Bill &amp; Melinda Gates Foundation</a> chose <a href="http://www.grandchallenges.org/Explorations/Pages/GrantsAwarded.aspx?Topic=Contraception&amp;Round=11&amp;Phase=1">11 winners</a>.
The foundation said it wanted to create a new generation of <keyword id="27993" type="UNKNOWN" weightage="60" keywordseo="condoms">condoms</keyword> "that significantly preserve or enhance pleasure." That way, guys will actually want to wear condoms and, in theory, the global rates of unplanned pregnancy and sexually transmitted infections will decrease.
Each winner received $100,000 to pursue their designs.
Check them out below: 
<ul>
<li>Heat conducting condom infused with antibacterial drugs: Graphene is a thin, crystalline form of carbon that's highly elastic and can conduct heat. Lakshminarayanan Ragupathy of HLL Lifecare Ltd. in India will produce condoms using graphene-based polymer composites. </li>
<li>Elastic condom: Using a new composite of elastic materials, a team from the University of Manchester in the United Kingdom proposes a condom that will feel more like skin-to-skin contact.</li>
<li>Self-tightening condom: Layering multiple polymers allows the condom to gently tighten during intercourse. The material will put less pressure on the skin and increase sensation at key moments. A team from Cambridge Design Partnership in the United Kingdom is designing it.</li>
<li>Mucous condom: A team from Northwestern University will create a new polymeric material that mimics the properties of mucosal tissue, essentially what your bodily mucous membranes already feel like. Thus, a very natural feeling during intercourse. </li>
<li>Break-resistant condom: A nanoparticle coating helps prevent condom breakage. The coating, developed by researchers at Boston University Medical Center, works by trapping a thin layer of water to reduce friction and tearing forces. </li>
<li>Shape memory condom: Body heat will quickly fix the shape of the condom to the individual wearer. Researchers at the University of Oregon will tailor condoms with polyurethane linear and elastomeric materials, both of which will improve tactility and increase sensitivity.</li>
<li>Wrapping condom: The California Family Health Council will make condoms that wrap and cling around the wearer instead of squeezing him. The non-toxic and hypoallergenic polyethylene condoms will also come with enhanced lubrication through a collaboration with a Colombian condom manufacturer.</li>
<li>Superelastomer condom:Superelastomer technology allows condoms to be made ultra-thin, ultra-soft, strong and tear resistant. It also has a low-cost production method which will encourage use in developing countries. Researchers at the University of Tennessee will develop it.</li>
<li>Cow tendon condom: Collagen fibers from cows' Achilles tendons, and possibly fish skin, will give the wearer more of a skin-to-skin feel with his partner. The materials in the condom, developed by researchers at Apex Medical Technologies in San Diego, will enhance strength and sensitivity.</li>
<li>The Rapidom: A condom with applicators attached to make putting it on possible with a single motion. Produced by Kimbranox Ltd. in South Africa, it makes application easier and, most importantly, helps get the condom on the right way. Putting the condom on inside-out, then reversing the direction, exposes a guy's partner to his pre-ejaculatory fluids and increases the risk for pregnancy and disease. </li>
<li>Condom Applicator Pack: A team from House of Petite Pty. Ltd. in Australia will build an applicator separate from the condom but sold in the same package. It's meant to keep the condom away from the wearer's hands, which can spread disease, and ensure the condom is put on in the right direction.</li>
</ul>

You Searched For "hll" and got 7 results

COVID-19 vaccine: India places orders for over 60 million doses from Serum, Bharat Biotech for ₹1,300 crore

PTI

Northern Railways' PPE samples clear DRDO test; 100 units a day to be produced soon

PTI

ICMR issues guidance on rapid antibody test kits for COVID-19, lists manufacturers

PTI

ICMR issues revised guidance document on rapid antibody test kits for COVID-19

PTI

The best budget printers

Les Shu

LeBron James is being tested like never before in the playoffs, and the biggest question in the NBA hangs over it

Scott Davis

These 11 Innovative Condoms Just Got Grants From The Bill & Melinda Gates Foundation

Paige Cooperstein